News About: Pharm. Industry
Choong-wae develops generic drug for imipenem
Choong-wae Pharm said on June 7 that it has succeeded in developing the first generic drug of imipenem, a broad-spectrum antibiotic following penicillin and cephalosporin families.
Imipenem, developed by the US dru...
SK Chemical took approval of an anti-coagulation drug.
SK Chemical and SK Pharmaceutical secured the KFDA approval of "Hootan", an anti-coagulation drug, for the treatment of blood coagulation and thrombo-embolism for patients on blood dialysis and acute pancreatitis, on ...
Boryung to set up SCM system.
Boryung Pharm. Co. announced that for the first time in the pharmaceutical industry of Korea they launched SCM (supply chain management) system in their purchase works, providing a package form of internet logistic se...
Sanofi-Synthelabo launches Cronosphere, innovative anti-epileptic drug
Sanofi-Synthelabo said it has launched Cronosphere, a novel dosage form of Depakine (sodium valproate) for the treatment of epilepsy.
Cronosphere is a sustained release dosage form using a prilling method.
Sphe...
815 drugs to be incentive items for substituted dispensing.
About 815 drugs could be under the category of "Incentive items for cheaper substituted dispensing" as of the end of May this year, which gives an incentive at about 30% out of the price differences of the cheap subst...
Domestic pharmaceutical industry rushes to expand global operations
Korea's pharmaceutical firms, including a major business interest group, are scurrying to expand their foreign operations in a bid to strength their presence in the global market beyond already saturated domestic phar...
Medium- and small-sized pharmaceutical firms now turn to Internet
Amid depressed consumer demand and a slumping economy, sales of domestic medium- and small-sized pharmaceutical firms involved in functional health foods and cosmetics, via Internet community and on-line shopping mall...
Preoccupation of lst generic drug registration in hot competition.
Most of leading domestic pharmaceutical companies are in severe competition for earlier registration of the copy products whose patents be terminated than the rivals in view of preoccupying the already well establishe...
Assigned bio-equivalent tests may reach 1,600 items this year.
When an entire process is assignable to the company authorized for the bio-equivalent tests, so called assigned bio-equivalent test, which recognized the equivalency even without actual tests when the bio-equivalent t...
Foreign makers battle for Korean lip protective market
Business sources say that the domestic lip protective market has emerged as an arena of competition between two foreign makers, Wyeth Korea and Nivea, as KGC Sang-A plans to discontinue its business operation of LipPl...
